HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, was profiled in the November 9, 2012 issue of Medical Device Daily in a featured “New Company On The Go” interview. Medical Device Daily, the world’s leading med-tech news and information source, is the daily source for world-wide developments in the medical community. SpinalCyte has successfully completed its first round of animal studies with Howard An, M.D. at Rush University in Chicago. Using intermittent hydrostatic pressure, the dermal cells have successfully differentiated into cartilage type cells necessary to regrow the nucleus pulposus.
